|
MED31 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.784130E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.739800E-03 |
| Normal-vs-Stage2 |
2.298200E-03 |
| Normal-vs-Stage3 |
4.475600E-03 |
| Normal-vs-Stage4 |
4.400900E-04 |
| Stage1-vs-Stage2 |
2.139000E-01 |
| Stage1-vs-Stage3 |
4.713800E-01 |
| Stage1-vs-Stage4 |
6.278100E-02 |
| Stage2-vs-Stage3 |
5.203000E-01 |
| Stage2-vs-Stage4 |
6.443200E-01 |
| Stage3-vs-Stage4 |
2.363600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.376100E-03 |
| Normal-vs-AfricanAmerican |
1.181490E-03 |
| Normal-vs-Asian |
1.000790E-01 |
| Caucasian-vs-AfricanAmerican |
1.790600E-01 |
| Caucasian-vs-Asian |
4.208000E-01 |
| AfricanAmerican-vs-Asian |
7.593600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.444930E-04 |
| Normal-vs-Female |
6.862500E-03 |
| Male-vs-Female |
1.271250E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.441820E-02 |
| Normal-vs-Age(41-60Yrs) |
7.160200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.855430E-03 |
| Normal-vs-Age(81-100Yrs) |
6.095200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.837820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.601020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.217600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.230000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.869800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.877200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.263900E-02 |
| Classical-VS-Follicular |
3.169800E-02 |
| Classical-VS-Other |
9.025000E-01 |
| Classical-VS-Normal |
1.586290E-02 |
| Tall-VS-Follicular |
7.537200E-01 |
| Tall-VS-Other |
2.185400E-01 |
| Tall-VS-Normal |
4.424300E-04 |
| Follicular-VS-Other |
4.491600E-01 |
| Follicular-VS-Normal |
5.975400E-04 |
| Other-VS-Normal |
4.182000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.537800E-03 |
| Normal-vs-N1 |
1.166000E-01 |
| N0-vs-N1 |
3.067800E-01 |
|
|
